Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion

J Periodontal Res. 2010 Feb;45(1):100-8. doi: 10.1111/j.1600-0765.2009.01206.x. Epub 2009 Jul 8.

Abstract

Background and objective: Porphyromonas gingivalis lipopolysaccharide (LPS) is a ligand for cell surface toll-like receptors (TLR), TLR2 and TLR4 while stimulation of either leads to cardioprotection. We hypothesized that: (1) pretreatment with P. gingivalis LPS at appropriate concentrations would induce cardioprotection against injury induced by ischemia and reperfusion; and (2) P. gingivalis LPS pretreatment at cardioprotective concentrations may reduce Ca(2+) overload, which is a precipitating cause of injury, and improve recovery of contractile function.

Material and methods: Male Sprague-Dawley rats were randomly selected to receive intraperitoneal saline or hot phenol-water-extracted P. gingivalis LPS at 0.2, 0.5, 1.0, 2.0 or 4.0 mg/kg 24 h before the experiment. The hearts were isolated and subjected to regional ischemia by coronary artery ligation followed by reperfusion. In isolated rat ventricular myocytes, the cytosolic Ca(2+) level and the electrically induced intracellular calcium (E[Ca(2+)](i)) transient, which reflects contractile function, were determined after pretreatment with a cardioprotective dose of P. gingivalis LPS.

Results: Pretreatment with 0.5 mg/kg P. gingivalis LPS significantly reduced, while pretreatment with 1.0-4.0 mg/kg significantly increased infarct size. The Ca(2+) overload induced by ischemia-reperfusion was attenuated in myocytes from rats pretreated with 0.5 mg/kg P. gingivalis LPS. Pretreated myocytes also showed an increased amplitude of the E[Ca(2+)](i) transient, no prolongation of the time to reach the peak E[Ca(2+)](i) transient and shorter 50% decay time during reperfusion.

Conclusion: At a dosage of 0.5 mg/kg, P. gingivalis LPS confers cardioprotection against ischemia-reperfusion-induced injury and improved intracellular E[Ca(2+)](i) transient recovery, hence improving myocyte contractile recovery.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Calcium / analysis
  • Calcium Channels / drug effects
  • Calcium Signaling / drug effects*
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / therapeutic use*
  • Cytosol / drug effects
  • Heart Ventricles / pathology
  • Injections, Intraperitoneal
  • Ischemic Preconditioning, Myocardial / methods*
  • Lipopolysaccharides / administration & dosage
  • Lipopolysaccharides / therapeutic use*
  • Male
  • Myocardial Contraction / drug effects
  • Myocardial Infarction / prevention & control
  • Myocardial Ischemia / pathology
  • Myocardial Ischemia / physiopathology
  • Myocardial Reperfusion Injury / prevention & control
  • Myocytes, Cardiac / drug effects
  • Porphyromonas gingivalis*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function / drug effects
  • Sarcolemma / drug effects
  • Sarcoplasmic Reticulum / drug effects
  • Time Factors

Substances

  • Calcium Channels
  • Cardiotonic Agents
  • Lipopolysaccharides
  • Calcium